42Atrial fibrillation ablation as a day-case procedure: three-year single-centre experience

Bartoletti, Stefano; Mann, Mandeep K.; Khan, A; Sahni, Ankita; Kadri, Moutaz El; Hobbs, Julian; Modi, S.; Waktare, Johan; Mahida, SN; Hall, M.; Snowdon, Richard; Todd, DM; Gupta, Dhiraj

doi:10.1093/europace/eux283.051

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Due to the aging population, increasing prevalence of AF risk factors, improving detection methods for AF, and broadening indications for ablation, in many centers, CA for AF is the most common resource-consuming ablation procedure performed, strongly impacting waiting list times and healthcare costs [5]. The combination of these factors and limited bed availability led to the development of a same-day discharge (SDD) protocol in some centers worldwide with acceptable efficacy and safety outcomes [6,7], and data supporting this approach are proliferating. SDD has already been shown to be safe and effective for non-complex ablations [8], cardiac implantable electronic device procedures, and left atrial appendage occlusion.…”

Section: Introductionmentioning

confidence: 99%

Micro-Costing Analysis for the Treatment of Atrial Fibrillation: An Economic Evaluation of the First Italian Experience of Same-Day Discharge Protocol for Cryoballoon Atrial Fibrillation Ablation

Sgarito,

Cascino,

Ferrara

et al. 2024

JCM

View full text Add to dashboard Cite

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its prevalence is expected to increase further due to the aging population, increasing prevalence of risk factors, improving detection methods, and broadening of catheter ablation indications. Along with limited healthcare resources and bed availability, these reasons led to the development of a same-day discharge (SDD) protocol. The aim of this study was to evaluate the health and economic impact of a routine adoption of same-day discharge after cryoballoon AF ablation. Methods: Consecutive patients with symptomatic and drug-refractory AF scheduled for first-time AF ablation were screened, and if deemed suitable, the SDD protocol was proposed and, if accepted, enrolled in the protocol. Results: A total of 324 patients were screened, and 118 were considered eligible for the SDD pathway. Fifty-two patients accepted the SDD pathway and were included in this study. The analysis showed that the variation in resource consumption associated with cryoablation in SDD is equal to EUR 739.85/patient. The analysis showed that the main cost driver for ordinary hospitalization was represented by the hospital stay, which was calculated to be 36% of the total cost. In total, there was a cost reduction of EUR 38.472 thanks to optimized AF patient management from the standard recovery setting to SDD. Conclusions: SDD after cryoballoon ablation of AF is feasible in selected patients with a standardized protocol.

show abstract